Quality-of-Life (QOL) during Screening for Phase 1 Trial Studies in Patients with Advanced Solid Tumors and Its Impact on Risk for Serious Adverse Events
Anwar, Sidra, Tan, Wei, Hong, Chi-Chen, Admane, Sonal, Dozier, Askia, Siedlecki, Francine, Whitworth, Amy, DiRaddo, Ann Marie, DePaolo, Dawn, Jacob, Sandra M, Ma, Wen Wee, Miller, Austin, Adjei, Alex A, Dy, Grace K
Published in Cancers (26.06.2017)
Published in Cancers (26.06.2017)
Get full text
Journal Article
Evaluation of Quality-of-life (QoL) in patients(pts) with advanced solid tumors as screening tool during phase 1 clinical trial recruitment- risk assessment for adverse events and subject replacement
Anwar, Sidra, Tan, Wei, Hong, Chi-Chen, Admane, Sonal, Dozier, Askia, Siedlecki, Francine, Whitworth, Amy, DiRaddo, Ann Marie, DePaolo, Dawn, Jacob, Sandra M, Ma, Wen Wee, Miller, Austin, Adjei, Alex A., Dy, Grace K.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A phase I study of the toll-like receptor 5 (TLR5) agonist, entolimod in patients (pts) with advanced cancers
Bakhribah, Hatoon, Dy, Grace K., Ma, Wen Wee, Zhao, Yujie, Opyrchal, Mateusz, Purmal, Andrei, Gollnick, Sandra, Brady, William E., Fetterly, Gerald J., Ngamphaiboon, Nuttapong, Reungwetwattana, Thanyanan, Jacob, Sandra M, O'Hara, Corrie, Siedlecki, Francine, Adjei, Araba, Burdelya, Lyudmila, Bespalov, Ivan, Miller, Langdon L., Gudkov, Andrei, Adjei, Alex A.
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article